Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

RJR-2403: CNS-selective nicotinic agonist with long-lasting beneficial effects on cognition

Nov. 16, 1998

Selective 5-HT7 receptor antagonist affects circadian rhythms in animal models

Nov. 16, 1998

Preclinical studies indicate OP-1 is effective three days after stroke

Nov. 16, 1998

SB team attempts to identify the source of antiparkinsonian activity of SKF-83959

Nov. 13, 1998

Neurobiological Technologies initiates phase IIb trial of memantine

Nov. 13, 1998

SCRAS presents new series of NOS and lipid peroxidation inhibitors

Nov. 13, 1998

Ligand and Elan finalize strategic alliance

Nov. 13, 1998

SB-205553 used to investigate role of 5-HT2C receptor antagonists in PD therapy

Nov. 13, 1998

SPBN: a free radical scavenger with potential in pediatric head trauma

Nov. 12, 1998

Pharmacological profile of the novel, selective kappa-opioid agonist HZ2

Nov. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...